New drug aims to unload the heart in lung hypertension
NCT ID NCT06658522
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether the drug sotatercept can improve right heart function in people with pulmonary arterial hypertension (PAH). PAH causes high blood pressure in the lungs, straining the right side of the heart. Sotatercept targets the underlying blood vessel changes, not just widening vessels. Twenty adults will receive injections every three weeks for 24 weeks, and doctors will measure heart function with imaging and catheterization. The goal is to see if the drug makes the heart work more efficiently.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sotatercept (a drug injected under the skin)
- What this could lead to
- If it works, this could show that sotatercept improves heart efficiency and delays right heart failure in people with pulmonary arterial hypertension.
- What could go wrong
- This is a small, early-phase study with only 20 participants and no placebo group, so results may not apply broadly. The drug may not improve heart function as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam UMC, location VUMC
RECRUITINGAmsterdam, North Holland, 1081HV, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an inhaled therapy replace a daily pill for PAH?
- Can a new pill ease the strain of pulmonary arterial hypertension?
- Could a gut bacteria transplant ease a rare lung disease?
- Can a diabetes drug help the heart burn fuel better in pulmonary hypertension?
- Can a Real-World registry improve how treprostinil is used for PAH?
- Can a smartwatch replace the clinic walk test for lung disease patients?